ash 2020: aml secondary to mds - updates for patients
Published 1 year ago • 89 plays • Length 55:36Download video MP4
Download video MP3
Similar videos
-
1:26:48
updates from ash 2020: promising treatment advances for mds and aml
-
58:15
ash 2020 mds updates
-
16:23
venetoclax in higher-risk mds/aml
-
3:49
excerpt: updates from ash 2019: the latest in mds and secondary aml 4/2/20
-
6:53
expert video report on acute myeloid leukemia and high risk mds from ash 2020
-
27:20
myelodysplastic syndromes and secondary aml: an update on diagnosis and treatment
-
6:13
treatments for mds and secondary aml - part 2, high-risk
-
19:37
2021 west oncology app | treatment options for elderly aml/mds patients
-
11:33
leukemia: seryosong sakit sa dugo: paano gamutin - by doc willie ong
-
3:16
myelomatch alc7 & al6 substudy for aml or mds - dr assouline & dr savoie interview
-
2:32
how quickly does aml progress? #aml
-
50:26
mds - aml - 2020 spring virtual conference: when mds becomes aml - for high-risk mds patients
-
1:01
do people who have their mds turn into aml all have a certain type of aml? #aml
-
31:41
advancing the treatment of mds and aml: an update from ash 2021
-
8:11
non transplant treatments for mds & secondary aml (co-chair summary)
-
6:46
case 2: aml with myelodysplasia-related changes
-
4:26
treatments for mds and secondary aml part 1, low-risk mds
-
6:37
low-risk mds updates from ash19
-
8:42
updates in the aml field at ash 2020
-
15:30
treatments for mds and secondary aml, with drs o. odenike and d. sallman
-
3:20
comparing the icc and who classifications for secondary aml and their impact on clinical practice
-
8:25
treating aml with mds-related changes